Adam Hacker

Adam Hacker is the Chair of the MHRA Review Panel at Medicines and Healthcare products Regulatory Agency. Prior to this role, Adam held positions such as Head of Global Regulatory Affairs and Quality at CEPI, SVP Global Head Regulatory Affairs and Quality at Autolus Ltd., and various leadership roles at The Janssen Pharmaceutical Companies of Johnson & Johnson, Johnson and Johnson, Biogen Idec, Amersham Health, and GlaxoSmithKline. Adam has a PhD in Molecular Developmental Biology from the National Institute for Medical Research and a BA Hon in Pure and Applied Biology from the University of Oxford.